Our results provide new insights into some of the bases for EGCG action in depression, which we hypothesize may involve modulation of IL-1β peripheral blood levels, BDNF expression in the hippocampus and neuronal ultrastructural damage in CUMS disorder. This evidence concerns the gene IL1B and depressive symptom measurement.